Anti-clever-1 Monoclonal Antibody FP-1305
Anti-clever-1 Monoclonal Antibody FP-1305 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-clever-1 Monoclonal Antibody FP-1305 is under investigation in clinical trial NCT03733990 (A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients).
| Trade Name | Anti-clever-1 Monoclonal Antibody FP-1305 |
| Generic | Bexmarilimab |
| Bexmarilimab Other Names | Anti-clever-1 monoclonal antibody FP-1305, Bexmarilimab, Clevegen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-clever-1 Monoclonal Antibody FP-1305
